Compare American Airlines Group Inc (AAL) vs ARK Genomic Revolution ETF (ARKG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Airlines Group Inc vs ARK Genomic Revolution ETF — how do they compare? American Airlines Group Inc trades at $15.06 (market cap $10.55B), while ARK Genomic Revolution ETF trades at $44.53. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, American Airlines Group Inc nearer its low. Which is the better fit depends on your goals.
| AAL | ARKG | |
|---|---|---|
Market Cap | $10.55B | — |
Sector | Industrials | Sector/Thematic |
52-Week High | $18.15 | $44.55 |
52-Week Low | $10.18 | $24.02 |
Enterprise Value | $38.51B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
American Airlines (AAL) trades at $15.06, up 0.37% today, with technical indicators showing a bearish bias despite recent earnings beats. The company reported mixed Q2 2026 results with revenue growth but faces margin pressure from fuel costs. Analyst consensus is a Buy with a $19.63 price target, though high debt and volatile profitability remain concerns.
AAL offers potential upside from its discounted valuation and premium revenue recovery, but investors face risks from fuel price volatility, high leverage, and competitive pressures. The stock's outlook hinges on sustained travel demand and cost management amid economic uncertainty.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Airlines Group Inc
American Airlines is the world's largest airline by scheduled revenue passenger miles. The firm's major hubs are Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C. After completing a major fleet renewal, the company has the youngest fleet of U.S. legacy carriers.
Read more on AAL →About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →
